Answers are grounded in this paper and cite their sources.
We carried out a double-blind and placebo-controlled study of the efficacy of bromocriptine in the treatment of nonfluent aphasia. Seven patients received bromocriptine (up to 60 mg/d) and an identical placebo in a randomized order. End points were the number of content words, content units, and pauses > 3 seconds during the description of a figure; verbal naming; and verbal fluency. There were no significant benefits of bromocriptine over placebo in any of the variables examined.
No takes yet. Share an insight, caveat, or question.
Sabe et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: